Cilia-specific cAMP plays a major role in aneurysm

Information

  • Research Project
  • 10214677
  • ApplicationId
    10214677
  • Core Project Number
    R01HL147311
  • Full Project Number
    5R01HL147311-02
  • Serial Number
    147311
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    7/15/2020 - 4 years ago
  • Project End Date
    6/30/2024 - 8 months ago
  • Program Officer Name
    MCDONALD, CHERYL
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    6/4/2021 - 3 years ago
Organizations

Cilia-specific cAMP plays a major role in aneurysm

PROJECT DESCRIPTION Cyclic adenosine monophosphate (cAMP) signaling regulates diverse pathways and cellular functions that result in specific responses when compartmentalized. However, the role of cAMP in cilia function is poorly understood, despite the implication of cAMP in the development of ciliopathies. Using two novel techniques, nanoparticle drug delivery and a single-cell imaging system, our preliminary data indicate that changes in cAMP within a cilium could be independent from those in the cytosol. Furthermore, we have preliminary evidence that inhibition of phosphodiesterase-3 (PDE3), an inactivator of cAMP, can restore ciliary function in ciliopathy models that are prone to aneurysm, and that aneurysmal vessels are characterized by genomic instability. Here, we hypothesize that ciliary cAMP plays an important role in aneurysm formation, and we propose to test if PDE3 is involved in vascular aneurysm via genomic instability (Aim 1) and clarify its role in cAMP signaling in primary cilia (Aim 2). Overall, we will test the idea if a single cilium could be a critical sensor acting as a responsive PDE/cAMP compartment.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    95000
  • Total Cost
    345000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NHLBI:345000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    MIST
  • Study Section Name
    Molecular and Integrative Signal Transduction Study Section
  • Organization Name
    CHAPMAN UNIVERSITY
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    072528433
  • Organization City
    ORANGE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    928661005
  • Organization District
    UNITED STATES